{"id":745280,"date":"2015-01-05T08:00:00","date_gmt":"2015-01-05T08:00:00","guid":{"rendered":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-hold-fourth-quarter-and-full-year-2014-sales-and-earnings-conference-call-on-february-4\/"},"modified":"2025-11-07T01:25:24","modified_gmt":"2025-11-07T06:25:24","slug":"merck-to-hold-fourth-quarter-and-full-year-2014-sales-and-earnings-conference-call-on-february-4","status":"publish","type":"news_item","link":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-hold-fourth-quarter-and-full-year-2014-sales-and-earnings-conference-call-on-february-4\/","title":{"rendered":"Merck to Hold Fourth-Quarter and Full-Year 2014 Sales and Earnings Conference Call on February 4"},"content":{"rendered":"<p>\n      Merck (NYSE:MRK), known as MSD outside the United States and Canada,<br \/>\n      will hold its fourth-quarter and full-year 2014 sales and earnings<br \/>\n      conference call with institutional investors and analysts at 8:00 a.m.<br \/>\n      EST on Wednesday, Feb. 4. During the call, company executives will<br \/>\n      provide an overview of Merck\u2019s performance for the quarter and full year.\n    <\/p>\n<p>\n      Investors, journalists and the general public may access a live audio<br \/>\n      webcast of the call on Merck\u2019s website at <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fvip2-msd.com\/merckcom-migrated%2Finvestors%2Fevents-and-presentations%2Fhome.html&amp;esheet=51011722&amp;newsitemid=20150105005105&amp;lan=en-US&amp;anchor=http%3A%2F%2Fvip2-msd.com\/merckcom-migrated%2Finvestors%2Fevents-and-presentations%2Fhome.html&amp;index=1&amp;md5=c835d14b197cd78754db60bdf0dfe658\" rel=\"nofollow\">http:\/\/vip2-msd.com\/merckcom-migrated\/investors\/events-and-presentations\/home.html<\/a>.<br \/>\n      A replay of the webcast will be available at approximately 11:00 a.m.<br \/>\n      EST on Feb. 4 and will remain on the website for 12 months. The sales<br \/>\n      and earnings news release and supplemental financial disclosures also<br \/>\n      will be available in the Newsroom and Investor sections of the company\u2019s<br \/>\n      website at <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fvip2-msd.com\/merckcom-migrated&amp;esheet=51011722&amp;newsitemid=20150105005105&amp;lan=en-US&amp;anchor=vip2-msd.com\/merckcom-migrated&amp;index=2&amp;md5=28921e4dc78c5f9dee72c88f178a3aa5\" rel=\"nofollow\">vip2-msd.com\/merckcom-migrated<\/a>.\n    <\/p>\n<p>\n      Institutional investors and analysts can participate in the call by<br \/>\n      dialing (706) 758-9927 or (877) 381-5782 and using ID code number<br \/>\n      54622693. Members of the media are invited to monitor the call by<br \/>\n      dialing (706) 758-9928 or (800) 399-7917 and using ID code number<br \/>\n      54622693. Journalists who wish to ask questions are requested to contact<br \/>\n      a member of Merck\u2019s Media Relations team at the conclusion of the call.\n    <\/p>\n<p>\n      <b>About Merck<\/b>\n    <\/p>\n<p>\n      Today\u2019s Merck is a global healthcare leader working to help the world be<br \/>\n      well. Merck is known as MSD outside the United States and Canada.<br \/>\n      Through our prescription medicines, vaccines, biologic therapies and<br \/>\n      animal health products, we work with customers and operate in more than<br \/>\n      140 countries to deliver innovative health solutions. We also<br \/>\n      demonstrate our commitment to increasing access to healthcare through<br \/>\n      far-reaching policies, programs and partnerships. For more information,<br \/>\n      visit <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fvip2-msd.com\/merckcom-migrated%2F&amp;esheet=51011722&amp;newsitemid=20150105005105&amp;lan=en-US&amp;anchor=vip2-msd.com\/merckcom-migrated&amp;index=3&amp;md5=4b481744119bcac2e7283d0bf2b76101\" rel=\"nofollow\">vip2-msd.com\/merckcom-migrated<\/a><br \/>\n      and connect with us on <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Fmerck&amp;esheet=51011722&amp;newsitemid=20150105005105&amp;lan=en-US&amp;anchor=Twitter&amp;index=4&amp;md5=5ebf075ffe3ee467f22b4fc3c4ea31e1\" rel=\"nofollow\">Twitter<\/a>,<br \/>\n      <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.facebook.com%2Fmerckbewell&amp;esheet=51011722&amp;newsitemid=20150105005105&amp;lan=en-US&amp;anchor=Facebook&amp;index=5&amp;md5=0598cb63d0324cd630d97a4041e50a94\" rel=\"nofollow\">Facebook<\/a><br \/>\n      and <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.youtube.com%2Fmerck&amp;esheet=51011722&amp;newsitemid=20150105005105&amp;lan=en-US&amp;anchor=YouTube&amp;index=6&amp;md5=741abd5b271f889af200f9a11a9e39ce\" rel=\"nofollow\">YouTube<\/a>.\n    <\/p>\n<p>\n      <b>Merck Forward-Looking Statement<\/b>\n    <\/p>\n<p>\n      This news release includes \u201cforward-looking statements\u201d within the<br \/>\n      meaning of the safe harbor provisions of the United States Private<br \/>\n      Securities Litigation Reform Act of 1995. These statements are based<br \/>\n      upon the current beliefs and expectations of Merck\u2019s management and are<br \/>\n      subject to significant risks and uncertainties. If underlying<br \/>\n      assumptions prove inaccurate or risks or uncertainties materialize,<br \/>\n      actual results may differ materially from those set forth in the<br \/>\n      forward-looking statements.\n    <\/p>\n<p>\n      Risks and uncertainties include but are not limited to, general industry<br \/>\n      conditions and competition; general economic factors, including interest<br \/>\n      rate and currency exchange rate fluctuations; the impact of<br \/>\n      pharmaceutical industry regulation and health care legislation in the<br \/>\n      United States and internationally; global trends toward health care cost<br \/>\n      containment; technological advances, new products and patents attained<br \/>\n      by competitors; challenges inherent in new product development,<br \/>\n      including obtaining regulatory approval; Merck\u2019s ability to accurately<br \/>\n      predict future market conditions; manufacturing difficulties or delays;<br \/>\n      financial instability of international economies and sovereign risk;<br \/>\n      dependence on the effectiveness of Merck\u2019s patents and other protections<br \/>\n      for innovative products; and the exposure to litigation, including<br \/>\n      patent litigation, and\/or regulatory actions.\n    <\/p>\n<p>\n      Merck undertakes no obligation to publicly update any forward-looking<br \/>\n      statement, whether as a result of new information, future events or<br \/>\n      otherwise. Additional factors that could cause results to differ<br \/>\n      materially from those described in the forward-looking statements can be<br \/>\n      found in Merck\u2019s 2013 Annual Report on Form 10-K and the company\u2019s other<br \/>\n      filings with the Securities and Exchange Commission (SEC) available at<br \/>\n      the SEC\u2019s Internet site (<a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov&amp;esheet=51011722&amp;newsitemid=20150105005105&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=7&amp;md5=9e6a68f8d5421d9e0bd503b3b104bef8\" rel=\"nofollow\">www.sec.gov<\/a>).\n    <\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"http:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20150105005105r1&amp;sid=hq1ny1&amp;distro=nx&amp;lang=en\" \/><span class=\"bwct31415\" \/><\/span><\/p>\n<p>       Merck<br \/>Media:<br \/>Lainie Keller, 908-236-5036<br \/>Steven Cragle,        908-740-1801<br \/>or<br \/>Investors:<br \/>Justin Holko, 908-740-1879<br \/>Joe        Romanelli, 908-740-1986     <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Merck (NYSE:MRK), known as MSD outside the United States and Canada, will hold its fourth-quarter and full-year 2014 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EST on Wednesday, Feb. 4. During the call, company executives will provide an overview of Merck\u2019s performance for the quarter and full year. Investors, journalists and the general public may access a live audio webcast of the call on Merck\u2019s website at http:\/\/vip2-msd.com\/merckcom-migrated\/investors\/events-and-presentations\/home.html. A replay of the webcast will be available at approximately 11:00 a.m. EST on Feb. 4 and will remain on the website for 12 months. The sales and earnings news release and supplemental financial disclosures also will be available in the Newsroom and Investor sections of the company\u2019s website at vip2-msd.com\/merckcom-migrated. Institutional investors and analysts can participate in the call by dialing (706) 758-9927 or (877) 381-5782 and using ID code number 54622693. Members of the<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"bdl_company_name":[],"bdl_item_external_link":[],"inpsyde_pem_expiration_date":[],"inpsyde_pem_expiration_action":[],"footnotes":""},"tags":[53,52,64,289],"class_list":["post-745280","news_item","type-news_item","status-publish","hentry","tag-corporate-news","tag-financial-news","tag-latest-news","tag-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Merck to Hold Fourth-Quarter and Full-Year 2014 Sales and Earnings Conference Call on February 4 - Merck.com<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-hold-fourth-quarter-and-full-year-2014-sales-and-earnings-conference-call-on-february-4\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Merck to Hold Fourth-Quarter and Full-Year 2014 Sales and Earnings Conference Call on February 4 - Merck.com\" \/>\n<meta property=\"og:description\" content=\"Merck (NYSE:MRK), known as MSD outside the United States and Canada, will hold its fourth-quarter and full-year 2014 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EST on Wednesday, Feb. 4. During the call, company executives will provide an overview of Merck\u2019s performance for the quarter and full year. Investors, journalists and the general public may access a live audio webcast of the call on Merck\u2019s website at http:\/\/vip2-msd.com\/merckcom-migrated\/investors\/events-and-presentations\/home.html. A replay of the webcast will be available at approximately 11:00 a.m. EST on Feb. 4 and will remain on the website for 12 months. The sales and earnings news release and supplemental financial disclosures also will be available in the Newsroom and Investor sections of the company\u2019s website at vip2-msd.com\/merckcom-migrated. Institutional investors and analysts can participate in the call by dialing (706) 758-9927 or (877) 381-5782 and using ID code number 54622693. Members of the\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-hold-fourth-quarter-and-full-year-2014-sales-and-earnings-conference-call-on-february-4\/\" \/>\n<meta property=\"og:site_name\" content=\"Merck.com\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-07T06:25:24+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20150105005105r1&amp;sid=hq1ny1&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-to-hold-fourth-quarter-and-full-year-2014-sales-and-earnings-conference-call-on-february-4\\\/\",\"url\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-to-hold-fourth-quarter-and-full-year-2014-sales-and-earnings-conference-call-on-february-4\\\/\",\"name\":\"Merck to Hold Fourth-Quarter and Full-Year 2014 Sales and Earnings Conference Call on February 4 - Merck.com\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-to-hold-fourth-quarter-and-full-year-2014-sales-and-earnings-conference-call-on-february-4\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-to-hold-fourth-quarter-and-full-year-2014-sales-and-earnings-conference-call-on-february-4\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20150105005105r1&amp;sid=hq1ny1&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2015-01-05T08:00:00+00:00\",\"dateModified\":\"2025-11-07T06:25:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-to-hold-fourth-quarter-and-full-year-2014-sales-and-earnings-conference-call-on-february-4\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-to-hold-fourth-quarter-and-full-year-2014-sales-and-earnings-conference-call-on-february-4\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-to-hold-fourth-quarter-and-full-year-2014-sales-and-earnings-conference-call-on-february-4\\\/#primaryimage\",\"url\":\"http:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20150105005105r1&amp;sid=hq1ny1&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"http:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20150105005105r1&amp;sid=hq1ny1&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-to-hold-fourth-quarter-and-full-year-2014-sales-and-earnings-conference-call-on-february-4\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"News\",\"item\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news-archive\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Merck to Hold Fourth-Quarter and Full-Year 2014 Sales and Earnings Conference Call on February 4\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/#website\",\"url\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/\",\"name\":\"Merck.com\",\"description\":\"Just another vip-msd.com site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Merck to Hold Fourth-Quarter and Full-Year 2014 Sales and Earnings Conference Call on February 4 - Merck.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-hold-fourth-quarter-and-full-year-2014-sales-and-earnings-conference-call-on-february-4\/","og_locale":"en_US","og_type":"article","og_title":"Merck to Hold Fourth-Quarter and Full-Year 2014 Sales and Earnings Conference Call on February 4 - Merck.com","og_description":"Merck (NYSE:MRK), known as MSD outside the United States and Canada, will hold its fourth-quarter and full-year 2014 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EST on Wednesday, Feb. 4. During the call, company executives will provide an overview of Merck\u2019s performance for the quarter and full year. Investors, journalists and the general public may access a live audio webcast of the call on Merck\u2019s website at http:\/\/vip2-msd.com\/merckcom-migrated\/investors\/events-and-presentations\/home.html. A replay of the webcast will be available at approximately 11:00 a.m. EST on Feb. 4 and will remain on the website for 12 months. The sales and earnings news release and supplemental financial disclosures also will be available in the Newsroom and Investor sections of the company\u2019s website at vip2-msd.com\/merckcom-migrated. Institutional investors and analysts can participate in the call by dialing (706) 758-9927 or (877) 381-5782 and using ID code number 54622693. Members of the","og_url":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-hold-fourth-quarter-and-full-year-2014-sales-and-earnings-conference-call-on-february-4\/","og_site_name":"Merck.com","article_modified_time":"2025-11-07T06:25:24+00:00","og_image":[{"url":"http:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20150105005105r1&amp;sid=hq1ny1&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-hold-fourth-quarter-and-full-year-2014-sales-and-earnings-conference-call-on-february-4\/","url":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-hold-fourth-quarter-and-full-year-2014-sales-and-earnings-conference-call-on-february-4\/","name":"Merck to Hold Fourth-Quarter and Full-Year 2014 Sales and Earnings Conference Call on February 4 - Merck.com","isPartOf":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/#website"},"primaryImageOfPage":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-hold-fourth-quarter-and-full-year-2014-sales-and-earnings-conference-call-on-february-4\/#primaryimage"},"image":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-hold-fourth-quarter-and-full-year-2014-sales-and-earnings-conference-call-on-february-4\/#primaryimage"},"thumbnailUrl":"http:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20150105005105r1&amp;sid=hq1ny1&amp;distro=nx&amp;lang=en","datePublished":"2015-01-05T08:00:00+00:00","dateModified":"2025-11-07T06:25:24+00:00","breadcrumb":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-hold-fourth-quarter-and-full-year-2014-sales-and-earnings-conference-call-on-february-4\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-hold-fourth-quarter-and-full-year-2014-sales-and-earnings-conference-call-on-february-4\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-hold-fourth-quarter-and-full-year-2014-sales-and-earnings-conference-call-on-february-4\/#primaryimage","url":"http:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20150105005105r1&amp;sid=hq1ny1&amp;distro=nx&amp;lang=en","contentUrl":"http:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20150105005105r1&amp;sid=hq1ny1&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-to-hold-fourth-quarter-and-full-year-2014-sales-and-earnings-conference-call-on-february-4\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"News","item":"https:\/\/vip2-msd.com\/merckcom-migrated\/news-archive\/"},{"@type":"ListItem","position":2,"name":"Merck to Hold Fourth-Quarter and Full-Year 2014 Sales and Earnings Conference Call on February 4"}]},{"@type":"WebSite","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/#website","url":"https:\/\/vip2-msd.com\/merckcom-migrated\/","name":"Merck.com","description":"Just another vip-msd.com site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vip2-msd.com\/merckcom-migrated\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":{"news_item_workflow_id":"2f65dbf3-ec42-4f8c-8695-6212588b2b85","news_item_aria_label":"","media_files":null,"document_path":"","file":""},"_links":{"self":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/745280","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item"}],"about":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/types\/news_item"}],"version-history":[{"count":1,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/745280\/revisions"}],"predecessor-version":[{"id":3674696,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/745280\/revisions\/3674696"}],"wp:attachment":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/media?parent=745280"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/tags?post=745280"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}